Global Healthcare

Digital Genome Market Size, Share and Forecast 2019-2026

Press release   •   Nov 08, 2019 16:08 GMT

The global digital genome market size crossed $26 billion in 2018 and expected to reach USD 50.7 billion by 2026 is projected to register over 10% CAGR up to 2026.

The high growth is ascribed to key factors such as rising consciousness of genetic roles in identification of chronic disorders such as cancer, rare disorders, diabetes etc. In addition, other vital factors impacting the development of market are growing elderly population and rise in demand for effective diagnosis of genetic disorders. Moreover, increasing number of drug inventions & upsurge in genomics research leading to expansion of the market.

The demand for digital genome is rapidly gaining popularity owing to continuous reduction in the cost and time required. The sequencing is widely used in the field of oncology, reproductive health and genetics. As a result, firms such as Illumina, Thermo Fisher and Qiagen are developing new innovative technologies in the field of genomics. Digital genomics market will further grow as rising application of sequencing in diagnosis of genetic disorders such as Duchenne Muscular Dystrophy, Fragile X syndrome and FAM Hypercholesterolemia etc. Advent of new technology coupled with rising demand of precision medicines will escalate digital genome market over forecast period.

Get the Free Sample Copy of Report@ https://www.visionresearchreports.com/report/sample/29093

The major factors limiting the growth of digital genome market is lack of awareness regarding the digital genome, security & privacy of patient data, and incorrect results. In addition, lack of trained staff for digital genome in various developing economies will further impede the industry growth.

The market for DNA/RNA analysis kits are growing rapidly. With increasing investments and funding for research on life science, the adoption of digital genome is growing rapidly. Furthermore, high demand for various genotypic analysis and protein analysis are significantly contributing towards demand of digital genomics. The key players operating in the market have further developed advanced process of analysis of genes. With escalating research for genetics, stem cells and oncology, the need for DNA / RNA analysis kits will increase over estimated time frame. The key players of market, Thermo Fisher Scientific, GenomeMe, BiogeniQ and Nanostring has a wide array of kits for tumor gene analysis. The companies have developed kits where quantification of protein as well as analysis of gene expression can be performed in one experiment. The increasing demand for tumor gene analysis and advanced platforms will further propel demand for genome in near future.

The report analyzes and forecasts the digital genome market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global digital genome market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the digital genome market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of digital genome market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part of the report preparation. Those reading the report will be able to get a detailed understanding about the market. Industry experts have verified and checked the data and information that have been taken from credible sources like websites, annual reports of companies, journals, and other resources. In order give the facts and data a pictorial form, diagrams, graphs, pie charts, and other representations have been used. That augments the visual appeal of the report and makes understanding it much easier.

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29093

Key Players:

F. Hoffmann-La Roche Ltd. is one of the leaders in biotechnology, in-vitro diagnostics and tissue-based cancer diagnostics. The company is operating in the industry since 1896 and undertakes various strategic initiatives including new product launch to strengthen its business. Other key players operating in global industry include Agilent Technologies, Becton Dickinson, Pacific Biosciences, Perkin Elmer, and Thermo Fisher. These companies adopt various policies such as acquisitions, mergers, geographic expansion, to expand business.

Key financial developments of a particular company and product & company overview are some of the elements that help in acquiring information about top vendors in the market. This particular section has also included a SWOT analysis of the companies featured in the report. This will help the audience in knowing about opportunities, strengths, threats and weaknesses that are facing by the key vendors in the chemical and material industry across the world. As the competitive landscape is the most valuable part of any report, it consists of all the required information for the detailed study of top players functioning in the industries. It is also an interesting part to find how exactly these key manufacturers implement various strategies to secure the top rank in the industry. Such an in-depth information is useful for the new entrants into the industry as they would be able to learn a bit from these key vendors. Similarly, the information provided in the research report will also be valuable for the renowned key players as well, as they come to know the strategies of their counterparts to sustain in the competitive industry.

Segmentation

By Product

  • Sequencing & analyzer instruments
  • DNA/RNA analysis kits
  • Sequencing chips
  • Sequencing & analysis software
  • Sample preparation instruments

By application

  • Microbiology
    • Biological
    • Clinical
    • Industrial
  • Reproductive & Genetic
  • Transplantation
  • Livestock and Agriculture
  • Forensics
  • Research and Development

By end-use

  • Academic Research Institutes
  • Diagnostics & Forensic Labs
  • Hospitals
  • Bio-pharmaceutical Companies

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

Report coverage

  • Analysis Period: 2015 – 2026
  • Base Year: 2018
  • Forecast Data: 2019 – 2026
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Report Coverage: Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global digital genome capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026)
  • Focuses on the key digital genome manufacturers, to study the capacity, production, value, market share and development plans in future
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks
  • To identify significant trends and factors driving or inhibiting the market growth
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29093

Table of Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data Sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Digital genome industry 3600 synopsis, 2015 - 2026 (USD Million)

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Application trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Digital Genome Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Successful completion of the human genome project

3.3.1.2. Growing funding for genomics

3.3.1.3. Developments in biotechnology

3.3.1.4. Increasing demand for personalized medicines

3.3.1.5. Reduced cost and high speed of DNA sequencing

3.3.1.6. Entry of new players and start-ups in developing economies

3.3.1.7. Rising prevalence of chronic diseases

3.3.2. Industry pitfalls & challenges

3.3.2.1. Lack of experienced professionals

3.3.2.2. Concerns pertaining to security and confidentiality of patient data

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By application

3.4.3. By end-use

3.5. Regulatory landscape

3.6. Reimbursement scenario

3.7. Industry Ecosystem

3.8. Technology landscape

3.9. Company Share analysis

3.10. Pricing Analysis

3.10.1. Porter's analysis

3.11. Competitive landscape, 2018

3.11.1. Strategy dashboard

3.12. PESTEL analysis

Chapter 4. Digital Genome Market, By Product

4.1. Digital genome market share by product, 2018 & 2026

4.2. Sequencing & analyzer instruments

4.2.1. Market size, 2015 – 2026 (USD Million)

4.3. DNA/RNA analysis kits

4.3.1. Market size, 2015 – 2026 (USD Million)

4.4. Sequencing chips

4.4.1. Market size, 2015 – 2026 (USD Million)

4.5. Sequencing & analysis software

4.5.1. Market size, 2015 – 2026 (USD Million)

4.6. Sample preparation instruments

4.6.1. Market size, 2015 – 2026 (USD Million)

Chapter 5. Digital Genome Market, By Application

5.1. Digital genome market share by application, 2018 & 2026

5.2. Microbiology

5.2.1. Market size, 2015 – 2026 (USD Million)

5.2.2. Biological

5.2.2.1. Market size, 2015 – 2026 (USD Million)

5.2.3. Clinical

5.2.3.1. Market size, 2015 – 2026 (USD Million)

5.2.4. Industrial

5.2.4.1. Market size, 2015 – 2026 (USD Million)

5.3. Reproductive & genetic

5.3.1. Market size, 2015 – 2026 (USD Million)

5.4. Transplantation

5.4.1. Market size, 2015 – 2026 (USD Million)

5.5. Livestock and agriculture

5.5.1. Market size, 2015 – 2026 (USD Million)

5.6. Forensics

5.6.1. Market size, 2015 – 2026 (USD Million)

5.7. Research and development

5.7.1. Market size, 2015 – 2026 (USD Million)

Chapter 6. Digital Genome Market, By End-use

6.1. Digital genome market share by application, 2018 & 2026

6.2. Diagnostics & forensic labs

6.2.1. Market size, 2015 – 2026 (USD Million)

6.3. Academic Research institutes

6.3.1. Market size, 2015 – 2026 (USD Million)

6.4. Hospitals

6.4.1. Market size, 2015 – 2026 (USD Million)

6.5. Bio-pharmaceutical companies

6.5.1. Market size, 2015 – 2026 (USD Million)

Chapter 7. Digital Genome Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.2.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.2.3. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.2.3.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.2.4. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.2.5. U.S.

7.2.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.2.5.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.2.5.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.2.5.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.2.6. Canada

7.2.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.2.6.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.2.6.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.2.6.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3. Europe

7.3.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.3.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.3. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.3.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.4. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3.5. Germany

7.3.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.5.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.5.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.5.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3.6. UK

7.3.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.6.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.6.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.6.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3.7. France

7.3.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.7.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.7.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.7.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3.8. Italy

7.3.8.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.8.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.8.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.8.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.3.9. Spain

7.3.9.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.3.9.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.3.9.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.3.9.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.4. Asia Pacific

7.4.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.4.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.4.3. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.4.3.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.4.4. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.4.5. China

7.4.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.4.5.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.4.5.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.4.5.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.4.6. Japan

7.4.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.4.6.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.4.6.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.4.6.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.4.7. India

7.4.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.4.7.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.4.7.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.4.7.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.4.8. Australia

7.4.8.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.4.8.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.4.8.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.4.8.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.5. Latin America

7.5.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.5.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.5.3. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.5.3.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.5.4. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.5.5. Brazil

7.5.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.5.5.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.5.5.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.5.5.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.5.6. Mexico

7.5.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.5.6.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.5.6.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.5.6.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.5.7. Argentina

7.5.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.5.7.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.5.7.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.5.7.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.6. MEA

7.6.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)

7.6.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.6.3. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.6.3.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.6.4. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.6.5. South Africa

7.6.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.6.5.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.6.5.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.6.5.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

7.6.6. Saudi Arabia

7.6.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)

7.6.6.2. Market estimates and forecast, by application, 2015 – 2026 (USD Million)

7.6.6.2.1. Market estimates and forecast, by microbiology, 2015 – 2026 (USD Million)

7.6.6.3. Market estimates and forecast, by end-use, 2015 – 2026 (USD Million)

Chapter 8. Company Profiles

8.1. Agilent Technologies Inc.

8.1.1. Business Overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. bioMerieux

8.2.1. Business Overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. Becton, Dickinson and Company

8.3.1. Business Overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. F. Hoffmann-La Roche Ltd.

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. GE Healthcare

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Genomic Health, Inc.

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. GenMark Diagnostics, Inc.

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. Illumina

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Inscripta Inc.

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. NanoString Technologies, Inc.

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. Strategic outlook

8.10.5. SWOT analysis

8.11. Pacific Bioscience

8.11.1. Business overview

8.11.2. Financial data

8.11.3. Product landscape

8.11.4. Strategic outlook

8.11.5. SWOT analysis

8.12. PerkinElmer Inc.

8.12.1. Business overview

8.12.2. Financial data

8.12.3. Product landscape

8.12.4. Strategic outlook

8.12.5. SWOT analysis

8.13. Quest Diagnostics

8.13.1. Business overview

8.13.2. Financial data

8.13.3. Product landscape

8.13.4. Strategic outlook

8.13.5. SWOT analysis

8.14. Regeneron Pharmaceuticals, Inc.

8.14.1. Business Overview

8.14.2. Financial data

8.14.3. Product landscape

8.14.4. Strategic outlook

8.14.5. SWOT analysis

8.15. Qiagen

8.15.1. Business Overview

8.15.2. Financial data

8.15.3. Product landscape

8.15.4. Strategic outlook

8.15.5. SWOT analysis

8.16. Thermo Fisher Scientific

8.16.1. Business overview

8.16.2. Financial data

8.16.3. Product landscape

8.16.4. Strategic outlook

8.16.5. SWOT analysis

Request to Buy This Premium Report From Here@ https://www.visionresearchreports.com/report/cart/29093